The FDA has approved centanafadine (Simtriyo, Otsuka) as a first-in-class treatment of attention-deficit/hyperactivity disorder (ADHD) in adult and pediatric patients. The once-daily extended-release capsule is approved for adults and children aged 6 year... See more
Newly released US dyslipidemia guidelines would expand recommendations for primary prevention statin therapy to 87.5 million US adults, new research suggested. Released in March, the 2026 American Heart Association/American College of Cardiology multisoci... See more
Medical cannabis has become an option for a growing number of conditions, but the evidence suggests its clinical benefits are far more limited than its popularity might imply. A recent review published in JAMA showed that although medical cannabis may ben... See more
Treatment with a 1940-nm nonablative fractional laser (NAFL) may modulate DNA methylation tied to skin aging as well as skin cancer biology, new research suggested. In a split-face pilot study, 22 adults received three treatments with a 1940-nm NAFL. One ... See more
SAN FRANCISCO — The next edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM) will be renamed as the Diagnostic and Scientific Manual of Mental Disorders as part of a broader effort to strengthen its scientific foundation and transfo... See more
